Le Lézard
Classified in: Health
Subject: MAT

Shady Grove Fertility (SGF) physician, Stephanie Beall, M.D., Ph.D., recognized as a 2022 Top Doctor by Baltimore magazine


Physician peers vote Dr. Stephanie Beall to Baltimore magazine's Top Doctors list for reproductive endocrinology/IVF.

BALTIMORE, Nov. 4, 2022   /PRNewswire-PRWeb/ -- Shady Grove Fertility (SGF) physician Stephanie Beall, M.D., Ph.D., is recognized as a 2022 Top Doctor for reproductive endocrinology/IVF in the region by Baltimore magazine. The Baltimore Top Doctors honor recognizes more than 900 physicians representing more than 100 specialties. Peer-chosen winners, including Dr. Beall, represent only 6 percent of the estimated 14,000 physicians licensed to practice in the magazine's readership area.

To arrive at the esteemed Top Doctors list, Baltimore magazine hosted an annual online survey where thousands of regional physicians nominated the "best of the best" doctors, for which roughly 20,000 physician names were submitted. Only those with the highest number of peer recommendations made the list.

"I'm thankful to my Baltimore patients for entrusting me with their fertility care and honored to be recognized by my physician peers as a Top Doctor in my field," shares Dr. Beall. "It is such a privilege to be able to help patients achieve their family-building goals. I am appreciative of my entire team and fellow doctors who work diligently and tirelessly to help our patients build their families."

Dr. Beall is board certified in obstetrics and gynecology (OB/GYN) and reproductive endocrinology and infertility (REI). She provides patient care at SGF's Towson, Maryland, location. Dr. Beall has a keen clinical interest in treating patients with diminished ovarian function and fertility preservation. Dr. Beall is passionate about working with patients coping with the stress of infertility, which she has been recognized for as the recipient of a Compassionate Doctor Award on Vitals.com.

"Dr. Beall was fantastic ? always made herself available for questions and concerns," shares one of Dr. Beall's patients. "She never hesitated to give us her honest opinion."

For people struggling to conceive, it may be time to consult a fertility specialist. Contact the SGF New Patient Center at 1-888-761-1967 or complete a brief online request form to schedule an in-person or virtual consult with an SGF physician. A physician consult is the first step toward pursuing a pregnancy with the help of SGF.

About Shady Grove Fertility (SGF)
SGF is a leading fertility and IVF center of excellence with more than 100,000 babies born from 30+ years of continuous innovation and patient-centered fertility care. With 50 locations, including the newest location in Raleigh, North Carolina, as well as throughout CO, FL, GA, MD, NY, PA, TX, VA, D.C., and Santiago, Chile, SGF offers patients in-person and virtual physician consults, delivers individualized care, accepts most insurance plans, and makes treatment affordable through innovative financial options, including 100% refund guarantees. SGF is among the founding partner practices of US Fertility, the largest physician-led partnership of top-tier fertility practices in the U.S. Call 1-888-761-1967 to schedule a new patient appointment or visit ShadyGroveFertility.com for more information.

Media Contact

Jean Dzierzak, Shady Grove Fertility, 301-545-1375, [email protected]

 

SOURCE Shady Grove Fertility


These press releases may also interest you

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

3 jui 2024
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: